These include BRCA1 (52,53), PCNA (54,55), PLK1 (56,57), MCM2 (58), CHEK2 (59,60), CDK2 (61) and MCM7 (62), suggesting that the network discovered here is likely to be involved in progression of lung cancer. The gene discussed is MCM2; the disease is lung cancer.